Back to Deals
Value Undisclosed
Summary
Forge Genetics has secured a licensing agreement with global pharmaceutical company AbbVie for its genome editing technology.
Summary of transaction details:
- Value: N/A
- Sector: Pharmaceutical
- Advisor: N/A
- Key Entities: Forge Genetics, AbbVie
- Location: East Midlands
Note: The partnership follows successful proof-of-concept work where Forge Genetics' technology demonstrated its potential in a limited field.
Lead Investor / Acquirer
AbbVie
Advising Broker
Undisclosed Firm
Related Deals in Pharmaceutical
Original Source
View the original press release or news article describing this transaction in full.
Read Original PostAI Insight Lenses
ProAI-generated analysis from four professional perspectives. Powered by PE Deals.
Sign in to unlock AI Lenses
Sign in